The BIOS team at Johns Hopkins University is delighted to be a part of Edge Therapeutics' clinical trial Newton-2 (Protocol #EG-01-1962-03) evaluating a new formulation to treat aneurysmal subarachnoid hemorrhage (aSAH). Our goal at BIOS will be to ensure that assessors at the clinical sites are well versed on the neurologic outcome assessments in this trial. We are providing online training course, assessment tools, and informational updates. Please see the menu for these materials.
Additionally, please feel free to contact us with any questions you may have. Meanwhile, we look forward to working with you!